![Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [T4P5-H12] - BSA and Azide free (ab288143) Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [T4P5-H12] - BSA and Azide free (ab288143)](https://www.abcam.com/ps/products/288/ab288143/Images/ab288143-477924-anti-sars-cov2-spike-RBD-antibody-T4P5H12-elisa.jpg)
Recombinant Anti-SARS-CoV-2 Spike Glycoprotein S1 antibody [T4P5-H12] - BSA and Azide free (ab288143)
![Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France - eBioMedicine Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6dd94c2d-9739-4c5e-b7c7-e379b8bf2a71/gr1_lrg.jpg)
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France - eBioMedicine
![Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression | SpringerLink Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12291-022-01030-2/MediaObjects/12291_2022_1030_Fig1_HTML.png)
Impact of Covishield Vaccination in Terms of SARS CoV-2 Neutralizing Antibody Expression | SpringerLink
![Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867420306206-fx1.jpg)